[1]冉俊宁,陈朝阳,冯 君,等.基于网络药理学探讨生脉散治疗快速性心律失常气阴两虚证作用机制[J].陕西中医,2021,(3):383-388,397.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.031]
　RAN Junning,CHEN Zhaoyang,FENG Jun,et al.Research on mechanism of Shengmaisan in treating tachyarrhythmia with Qiyin Liangxu based on network pharmacology[J].,2021,(3):383-388,397.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.031]
点击复制

基于网络药理学探讨生脉散治疗快速性心律失常气阴两虚证作用机制
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年3期
页码:
383-388,397
栏目:
方药纵横
出版日期:
2021-03-09

文章信息/Info

Title:
Research on mechanism of Shengmaisan in treating tachyarrhythmia with Qiyin Liangxu based on network pharmacology
作者:
冉俊宁1; 陈朝阳1; 冯 君2; 刘建和2
(1.湖南中医药大学,湖南 长沙410208; 2.湖南中医药大学第一附属医院,湖南 长沙410007)
Author(s):
RAN Junning; CHEN Zhaoyang; FENG Jun; LIU Jianhe
(Hunan University of Chinese Medicine,Changsha 410208,China)
关键词:
生脉散;  快速性心律失常;  网络药理学;  气阴两虚;  活性成分;  心悸
Keywords:
Shengmaisan;  Tachyarrhythmia;  Network pharmacology;  Qiyin Liangxu;  Active components;  Palpitations
分类号:
R 289
DOI:
DOI:10.3969/j.issn.1000-7369.2020.03.031
文献标志码:
A
摘要:
目的:利用网络药理学方法探讨生脉散治疗快速性心律失常气阴两虚证可能的机制。方法:在TCMSP、Batman-TCM数据库筛选生脉散活性成分,利用Pubchem、Chemspider、 Swiss target prediction数据库预测相关靶点,Genecards数据库预测快速性心律失常靶点,二者取交集得到共同靶点。利用String数据库、Cytoscape软件构建共同靶点PPI网络图并得到Degree值。在DAVID数据库进行GO、KEGG分析,并利用Cytoscape软件构建靶点-通路网络图。结果:本研究收集到生脉散活性成分52个,活性成分相关靶点1672个,快速性心律失常靶点223个,共同靶点46个,以ACE、SRC、NOS3等相互作用最明显,共同靶点以多种方式参与调控蛋白激酶B信号转导、钙离子运输、钾离子转运等91个生物过程,并参与调节钙、cGMP-PKG、VEGF、MAPK等19个信号通路。结论:生脉散可能通过调控钙离子运输、钾离子转运、内皮功能、氧化应激等机制发挥其多活性成分、多靶点、多通路的治疗快速性心律失常气阴两虚证的作用。
Abstract:
Objective:To explore the possible mechanisms of Shengmaisan in treating tachyarrhythmia with Qiyin Liangxu through network pharmacology.Methods:The active components of Shengmaisan were screened on the TCMSP and Batman-TCM databases.Its relevant targets were predicted by the Pubchem and Chemspider and Swiss target prediction databases.Genecards database was used to predict the tachyarrhythmia targets.Both targets constructed venn diagrams to obtain common targets.String database and Cytoscape software were used to construct common target PPI network diagram and get the Degree value.The GO and KEGG analysis were performed in the DAVID database,and the target-pathway network map was constructed using Cytoscape software.Results:The study totally collected 52 active components of Shengmaisan,1672 related targets of active components,223 targets of tachyarrhythmia,46 common targets ACE,SRC and NOS3 interacted most obviously.The common targets were involved in regulating 91 biological processes mainly including protein kinase B signaling,calcium ion transport and potassium ion transport in various ways.Its participated in regulating 19 signal pathways mainly including calcium,cGMP-PKG,VEGF and MAPK.Conclusion:Shengmaisan treated tachyarrhythmia with Qiyin Liangxu type by regulating calcium transport,potassium transport,endothelial function,oxidative stress.

参考文献/References:

[1] 陈志强,杨关林.中西医结合内科学[M].北京:中国中医药出版社,2016:144.
[2] Chugh SS,Havmoeller R,Narayanan K,et al.Worldwide epidemiology of atrial fibrillation:A global burden of disease 2010 study[J].Circulation,2014,129(8):837-847.
[3] Patel NJ,Deshmukh A,Pant S,et al.Contemporary trends of hospitalization for atrial fibrillation in the United States 2000 through 2010:Implications for healthcare planning[J].Circulation,2014,129(23):2371-2379.
[4] Van IC,Rienstra M,Crijns HJ,et al.Rate control in atrial fibrillation[J].Lancet,2016,388(10046):818-828.
[5] Lau DH,Nattel S,Kalman JM,et al.Modifiable risk factors and atrial fibrillation[J].Circulation,2017,136(6):583-596.
[6] Haissaguerre M,Vigmond E,Stuyvers B,et al.Ventricular arrhythmias and the his purkinje system[J].Nature Reviews Cardiology,2016,13(3):155-166.
[7] 丛 丛,张蕴慧,胡 莹.心疾宁方治疗阴虚火旺型快速性心律失常的疗效及作用机制探讨[J].中药药理与临床,2020,36(3):231-234.
[8] 冯 君,刘建和,冉俊宁,等.从痰、瘀、虚探讨动脉粥样硬化的中西医病机[J].陕西中医,2020,41(2):217-219.
[9] Liu Z,Guo F,Wang Y,et al.Batman-TCM:A bioinformatics analysis tool for molecular mechanism of traditional Chinese medicine[J].Scientific Reports,2016,6(1):211-216.
[10] 杜 霞,李鹤鸣,陈志永,等.基于网络药理学方法研究补肾活血方治疗肾纤维化药效物质基础及分子作用机制[J].陕西中医,2018,39(11):1637-1641.
[11] 冉俊宁,冯 君,黄 巍,等.基于网络药理学探讨柴胡三参汤治疗缺血性心律失常的作用机制[J].中医药学报,2020,48(3):32-37.
[12] 杨仁义,刘利娟,康 蕾,等.基于网络药理学的活血荣络方对脑梗死血管新生作用机制研究[J].中国中医药信息杂志,2020,27(8):98-105.
[13] Lim KH,Ko D,Kim JH.Cardioprotective potential of Korean red ginseng extract on isoproterenol-induced cardiac injury in rats[J].Journal of Ginseng Research,2013,37(3):273-282.
[14] Lim KH,Cho JY,Kim B,et al.Red ginseng(panax ginseng)decreases isoproterenol-induced cardiac injury via antioxidant properties in porcine[J].Journal of Medicinal Food,2014,17(1):111-118.
[15] Mancuso C,Santangelo R.Panax ginseng and panax quinquefolius:From pharmacology to toxicology[J].Food and Chemical Toxicology,2017,107(5):362-372.
[16] 王 巍,苏光悦,胡婉琦,等.近10年人参皂苷对心血管疾病的药理作用研究进展[J].中草药,2016,47(20):3736-3741.
[17] Zhu D,Wu L,Li CR,et al.Ginsenoside Rg1 protects rat cardiomyocyte from hypoxia/reoxygenation oxidative injury via antioxidant and intracellular calcium homeostasis[J].Journal of Cellular Biochemistry,2009,108(1):117-124.
[18] Shi ZY,Zeng JZ,Wong A.Chemical structures and pharmacological profiles of ginseng saponins[J].Journal of Synthetic Chemistry and Natural Product Chemistry,2019,24(13):2443-2446.
[19] 于 晨.人参皂苷对心血管系统药理作用的研究[J].天津药学,2010,22(4):45-47.
[20] Zhao X,Xiang Y,Cai C,et al.Schisandrin B protects against myocardial ischemia/reperfusion injury via the PI3K/Akt pathway in rats[J].Molecular Medicine Reports,2018,17(1):556-561.
[21] Zhang W,Sun Z,Meng F.Schisandrin B ameliorates myocardial ischemia/reperfusion injury through attenuation of endoplasmic reticulum stress-induced apoptosis[J].Inflammation,2017,40(6):1903-1911.
[22] You WT,Zhou T,Ma ZC,et al.Ophiopogonin D maintains Ca2+ homeostasis in rat cardiomyocytes in vitro by upregulating CYP2J3/EETs and suppressing ER stress[J].Acta Pharmacologica Sinica,2016,37(3):368-381.
[23] Huang X,Wang Y,Wang YL,et al.Ophiopogonin D reduces myocardial ischemia-reperfusion injury via upregulating CYP2J3/EETs in rats[J].Cellular Physiology and Biochemistry,2018,49(4):1646-1658.
[24] Bernstein KE,Khan Z,Giani JF,et al.Angiotensin-converting enzyme in innate and adaptive immunity[J].Nature Reviews Nephrology,2018,14(5):325-336.
[25] Lu H,Cassis LA,Kooi CW,et al.Structure and functions of angiotensinogen[J].Hypertension Research,2016,39(7):492-500.
[26] Wu CH,Mohammadmoradi S,Chen JZ,et al.Renin-angiotensin system and cardiovascular functions[J].Arteriosclerosis Thrombosis and Vascular Biology,2018,38(7):108-116.
[27] Callera GE,Antunes TT,He Y,et al.Src inhibition improves cardiovascular function but not remodeling or fibrosis in angiotensin Ⅱ-induced hypertension[J].Hypertension,2016,68(5):1179-1190.
[28] Daiber A,Xia N,Steven S,et al.New therapeutic implications of endothelial nitric oxide synthase function/dysfunction in cardiovascular disease[J].International Journal of Molecular Sciences,2019,20(1):187-190.
[29] 刘建和,杨成龙,苏联军,等.柴胡三参胶囊对缺血性心律失常大鼠模型心肌细胞HERG K+通道蛋白的研究[J].湖南中医药大学学报,2016,36(6):16-19.
[30] 刘建和,赵吉锐,雷娄芳,等.柴胡三参胶囊含药血清对骨髓间充质干细胞分化为心肌细胞过程中PI3-K/Akt信号通路干预[J].辽宁中医药大学学报,2018,20(8):15-18.
[31] 刘建和,何少平,胡熙苒,等.柴胡三参胶囊对心肌缺血心律失常模型大鼠心肌细胞Ca2+及SERCA2a mRNA表达的影响[J].中华中医药杂志,2010,25(10):1574-1576.
[32] Weiss JN,Qu Z,Shivkumar K.Electrophysiology of hypokalemia[J].Circulation Arrhythmia and Electrophysiology,2017,10(3):466-467.
[33] Berridge MJ.The inositol trisphosphate/calcium signaling pathway in health and disease[J].Physiological Reviews,2016,96(4):1261-1296.
[34] Kovacs A,Alogna A,Post H,et al.Is enhancing cGMP-PKG signalling a promising therapeutic target for heart failure with preserved ejection fraction[J].Netherlands Heart Journal,2016,24(4):268-274.
[35] 张 圆,曹志鹏,毛瑞明,等.HIF-1α、VEGF-A在心律失常大鼠心肌组织中的变化[J].法医学杂志,2017,33(3):225-231.
[36] Ai X,Yan J,Carrillo E,et al.The stress-response MAP kinase signaling in cardiac arrhythmias[J].Reviews of Physiology,2016,172(17):77-100.

相似文献/References:

[1]冯 慧,吴钟伟,郑伟明,等.养阴清心化瘀方联合复方罗布麻治疗快速性心律失常疗效及对患者实验室指标水平的影响[J].陕西中医,2020,(4):471.

备注/Memo

备注/Memo:
基金项目:湖南省自然科学基金资助项目(2018JJ6038); 湖南省中医药科研计划项目(201703); 湖南省学位与研究生教育改革研究项目(2019JGYB163)
更新日期/Last Update: 2021-03-08